Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wattana Karnpaet PCLBKK:NEW 76 Forward PE Ratio is 0.00 as of Aug. 01, 2026. GuruFocus rates BKK:NEW with a GF Score™ of 76/100 and a GF Value™ of ฿96.79 (Fairly Valued). The stock has 1 warning sign investors should review. Among 314 Healthcare Providers & Services companies, Wattana Karnpaet PCL ranks worse than 318471.02% on this metric.
Wattana Karnpaet PCL (BKK:NEW) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Wattana Karnpaet PCL Forward PE Ratio Related Terms
Wattana Karnpaet PCL Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Wattana Karnpaet PCL's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wattana Karnpaet PCL Forward PE Ratio Chart
Wattana Karnpaet PCL Annual Data
Trend
Forward PE Ratio
Wattana Karnpaet PCL Quarterly Data
Forward PE Ratio
BKK:NEW vs HCA, THC, DVA: Forward PE Ratio Comparison
For the Medical Care Facilities subindustry, Wattana Karnpaet PCL's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wattana Karnpaet PCL Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Wattana Karnpaet PCL's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Wattana Karnpaet PCL's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Wattana Karnpaet PCL (BKK:NEW) has a Forward PE Ratio of 0.00 as of Aug. 01, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Wattana Karnpaet PCL and its competitors. According to the industry distribution chart, Wattana Karnpaet PCL ranks #999999 out of 314 companies in the Healthcare Providers & Services industry.
Is Wattana Karnpaet PCL's Forward PE Ratio too high?
Wattana Karnpaet PCL's current Forward PE Ratio is 0.00. Based on the distribution chart, Wattana Karnpaet PCL ranks #999999 out of 314 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Wattana Karnpaet PCL has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wattana Karnpaet PCL's Forward PE Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Wattana Karnpaet PCL ranks #999999 out of 314 companies for Forward PE Ratio. This places Wattana Karnpaet PCL in the lower half of its industry. The industry median Forward PE Ratio is 18.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 18.38, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Wattana Karnpaet PCL and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 18.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wattana Karnpaet PCL's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wattana Karnpaet PCL stock overvalued right now?
Based on GuruFocus' analysis, Wattana Karnpaet PCL (BKK:NEW) is currently considered Fairly Valued. The stock's GF Value™ is ฿96.79, compared to a current price of ฿95.00 — trading 1.8% below its estimated fair value. The current Forward PE Ratio is 0.00. Wattana Karnpaet PCL's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Wattana Karnpaet PCL (BKK:NEW), the current Forward PE Ratio is 0.00 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wattana Karnpaet PCL (BKK:NEW) Overvalued in 2026?
Based on GuruFocus' analysis, Wattana Karnpaet PCL stock appears to be undervalued.
The current stock price of ฿95.00 is trading 1.8% below its estimated GF Value™ of ฿96.79.
GuruFocus considers Wattana Karnpaet PCL to be Fairly Valued.
Key valuation signals for BKK:NEW:
Forward PE Ratio: 0.00
GF Value™: ฿96.79 vs. price of ฿95.00 (1.8% below fair value)
No single metric tells the full story. See the BKK:NEW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wattana Karnpaet PCL is engaged in the operation of a hospital under the name North Eastern Wattana Hospital. It has a single segment of operation, namely the hospital and medical trading business. The company earns revenue from hospital, revenue from sales of medicines, and revenue from hospital rooms, which are derived from the provision of services to various types and a large number of customers. Geographically, the company's operations are carried out in Thailand.
76GF Score
Get the complete analysis for BKK:NEW
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:NEW has been successfully added to your 
